Bevacizumab improves splenomegaly and decreases production of hyaluronic acid after L-OHP based chemotherapy.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Anticancer Research

• Publication date

  2014-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 24692731
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Perioperative change in peripheral blood monocyte count may predict prognosis in patients with colorectal liver metastasis after hepatic resection

  2012cited by this paper
• Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury.

  2010cited by this paper
• Predicting High Grade Lesions of Sinusoidal Obstruction Syndrome Related to Oxaliplatin-Based Chemotherapy for Colorectal Liver Metastases: Correlation With Post-Hepatectomy Outcome

  2010cited by this paper
• Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin‐associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis

  2010cited by this paper
• Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases.

  2009cited by this paper
• Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE).

  2008cited by this paper
• Chemotherapy‐associated hepatotoxicity and surgery for colorectal liver metastases

  2007cited by this paper
• Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin‐based chemotherapy for colorectal liver metastases

  2007cited by this paper
• Role of the actin cytoskeleton during respiratory burst in chemoattractant‐stimulated neutrophils

  2006cited by this paper
• Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases.

  2006cited by this paper
• GI complications in pediatric patients post-BMT

  2005cited by this paper
• Liver disease is a major cause of mortality following allogeneic bone-marrow transplantation

  2004cited by this paper
• Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

  2004cited by this paper
• Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition.

  2003cited by this paper
• Veno-occlusive disease of the liver in children with solid tumors undergoing autologous hematopoietic progenitor cell transplantation: a high incidence in patients with neuroblastoma

  2002cited by this paper
• Serum hyaluronic acid in patients with veno-occlusive disease following bone marrow transplantation

  2001cited by this paper
• Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis.

  2000cited by this paper
• Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of alpha-interferon therapy.

  1995cited by this paper
• Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyl-neoglycoalbumin.

  1991cited by this paper
• Serum hyaluronate in primary biliary cirrhosis—A biochemical marker for progressive liver damage

  1988cited by this paper

• Drug-induced hepatic sinusoidal obstruction syndrome: current advances and future perspectives

  2024influential citation
• Impact of neoadjuvant chemotherapy on the difficulty and outcomes of laparoscopic and robotic major liver resections for colorectal liver metastases: A propensity-score and coarsened exact-matched controlled study.

  2023cites this paper
• Impact of neoadjuvant chemotherapy on post-hepatectomy regeneration for patients with colorectal cancer liver metastasis - Systematic review and meta-analysis.

  2023cites this paper
• Oxaliplatin-induced hepatic sinusoidal obstruction syndrome.

  2021cites this paper
• Bevacizumab Does Not Influence the Efficacy of Partial Splenic Embolization in the Management of Chemotherapy-Induced Hypersplenism.

  2020cites this paper
• Oxaliplatin-induced haematological toxicity and splenomegaly in mice

  2020cites this paper
• Research progress of sinusoidal obstruction syndrome associated with oxaliplatin

  2020cites this paper
• Impact of Bevacizumab on Liver Damage After Massive Hepatectomy in Rats

  2019cites this paper
• Sinusoidal Obstruction Syndrome (Veno-occlusive Disease) Following Hematopoietic Stem Cell Transplant: Insights and Therapeutic Advances.

  2018cites this paper
• Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS

  2018cites this paper
• The hepatoprotective role of reduced glutathione and its underlying mechanism in oxaliplatin-induced acute liver injury

  2017cites this paper
• Manifestations and management of veno-occlusive disease/sinusoidal obstruction syndrome in the era of contemporary therapies.

  2017cites this paper
• Assessing splenic enlargement on CT by unidimensional measurement changes in patients with colorectal liver metastases

  2015cites this paper